WA
AZN icon

Westfuller Advisors’s AstraZeneca AZN Stock Holding History

Westfuller Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.7K Sell
166
-876
-84% -$169K 0.01% 306
2025
Q4 		$192K Sell
1,042
-21
-2% -$3.68K 0.08% 149
2025
Q3 		$163K Buy
+1,063
New +$161K 0.07% 170

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Westfuller Advisors's AZN Position: Q1 2026 in Review

Westfuller Advisors reduced its AstraZeneca (AZN) stake by 84% in Q1 2026, selling an estimated $169K and leaving 166 shares worth $32.7K. The position accounts for 0.01% of the portfolio, ranked #306.

Westfuller Advisors first reported a position in AZN in Q3 2025 and has held it in 3 quarters since. The position peaked at $192K in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Westfuller Advisors held 166 shares of AstraZeneca worth $32.7K as of Q1 2026.
  • Westfuller Advisors sold 876 AstraZeneca shares in Q1 2026, an estimated $169K.
  • AstraZeneca made up 0.01% of Westfuller Advisors's portfolio in Q1 2026, its #306 holding.
  • Westfuller Advisors first reported a position in AstraZeneca in Q3 2025 and has held it in 3 quarters since.
  • Westfuller Advisors's AstraZeneca position peaked at $192K in Q4 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Westfuller Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.